Carnitine and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carnitine (l - carnitine) and Tacrolimus (tacrolimus). Common drug interactions include dyskinesia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Carnitine and Tacrolimus. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Carnitine?

Carnitine has active ingredients of l - carnitine. eHealthMe is studying from 1,808 Carnitine users. Check the latest studies of Carnitine.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

14 people who take Carnitine and Tacrolimus together, and have interactions are studied.

Carnitine and Tacrolimus drug interactions.

What are the common drug interactions of Carnitine and Tacrolimus, by gender? *:

female:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  3. Blood erythropoietin decreased
  4. Blood lactate dehydrogenase increased
  5. Blood lactic acid increased
  6. Cytomegalovirus colitis (an inflammation of the colon from virus)
  7. Diarrhoea
  8. Dyspnoea (difficult or laboured respiration)
  9. Electrocardiogram st segment depression
  10. Fatigue (feeling of tiredness)

male:

  1. Chronic kidney disease
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Asthenia (weakness)
  4. Blood pressure increased
  5. Chest discomfort

What are the common drug interactions of Carnitine and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

30-39:

n/a

40-49:

  1. Blood lactic acid increased
  2. Cytomegalovirus colitis (an inflammation of the colon from virus)
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Electrocardiogram st segment depression
  6. Fatigue (feeling of tiredness)
  7. Haematochezia (passage of stools containing blood)
  8. Lymphocyte count decreased
  9. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

50-59:

n/a

60+:

  1. Asthenia (weakness)
  2. Blood pressure increased
  3. Chest discomfort

What are the existing conditions these people have? *

  1. Methylmalonic Aciduria (a disorder, passed down through families, in which the body cannot break down certain proteins and fats and result acid in urine): 3 people, 21.43%
  2. Immunodeficiency Disorders: 3 people, 21.43%
  3. Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 14.29%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.14%
  5. Hyperammonaemia: 1 person, 7.14%
  6. Diarrhea: 1 person, 7.14%
  7. Cystinosis (abnormal accumulation of the amino acid cystine): 1 person, 7.14%
  8. Constipation: 1 person, 7.14%
  9. Cardiac Failure: 1 person, 7.14%
  10. Amino Acid Metabolism Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Carnitine and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carnitine and Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on l - carnitine and tacrolimus (the active ingredients of Carnitine and Tacrolimus, respectively), and Carnitine and Tacrolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: